Qualification : M. Pharm., Ph.D., MBA, DCT
Specialization : Pharmaceutics
E mail : snkoteswararao.g@nmims.edu
Phone : 022-42332000 (Extn-2032)
Experience : 16 years
During the tenure of 16 years, Dr. S N Koteswara Rao G, served several institutions at different capacities like Vice-Principal, Professor and Head during which major administrative responsibilities like NBA, NIRF, NAAC & PCI were successfully accomplished in addition to academic & research portfolios. To his credit, he has guided 36 M.Pharm projects and published 94 papers in several indexed journals. To his credit, published 10 book chapters with reputed publishers like Elsevier, Springer, Taylor & Francis, & Wiley. He has successfully guided 3 Ph.D candidates and currently guiding 6 research scholars. He presented his research works at American Association of Pharmaceutical Scientists (AAPS) Exposition held at San Diego, California, USA. He is a recipient of gold medal and silver medals. He was trained at 3 levels by IIT Bombay for ICT enabled teaching & NITTR/UKIERI. His major areas of academic interest include OBE, ICT tools, game based learning, flipped classroom teaching etc.
Interest areas:
Research
Projects: 4
Conferences/Workshops/Seminars attended: 70
Academic activities
He has guided 36 M.Pharm. students for their research projects.
He has guided 3 PhDs successfully and 6 candidates are registered for PhD under his supervision.
Awards
Professional Memberships
Recent Publications
Nanoformulation-based Drug Delivery System for Viral Diseases. Pharmaceutical Nanotechnology, 2022; 36464883.
(Cite Score: 5.0; Impact Factor: 2.5) Q2
A spotlight on alkaloid nanoformulations for the treatment of lung cancer. Frontiers in Oncology, 2022; 994155.
(Cite Score: 4.5; Impact Factor: 6.244) Q1
Compression coated pulsatile chronomodulated therapeutic system: QbD assisted optimization. Drug Delivery, 2022; 29(1):2258-68.
(Cite Score: 10.2; Impact Factor: 6.819) Q1
The Race to Replace PDE5i: Recent Advances and Interventions to Treat or Manage Erectile Dysfunction: Evidence from Patent Landscape (2016–2021). Journal of Clinical Medicine, 2022; 11(11): 3140.
(Cite Score: 4.4; Impact Factor: 4.964) Q1
Development, statistical optimization and characterization of fluvastatin loaded solid lipid nanoparticles: A 32 factorial design approach. Pharmaceutics. 2022; 14: 584.
(Cite Score: 6.0; Impact Factor: 6.525) Q1